Our study demonstrates that PRMT6 acts as an oncogene in glioblastoma, and inhibiting PRMT6 through knockdown or using the inhibitor EPZ020411 notably decreased the invasion and migration of glioblastoma cells. This evidence concerns the gene PRMT6 and glioblastoma.